TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Hospital to pay $24.3M over TAVR allegations
According to a whistleblower, Cape Cod Hospital performed hundreds of TAVR procedures without following specific government requirements.
Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days
The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care.
TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms
Researchers tracked data from more than 7,500 patients, sharing their findings at EuroPCR 2024 in Paris and in JSCAI.
Updated balloon-expandable TAVR valve from Edwards outperforming its predecessors
The fifth-generation valve is associated with improved hemodynamic data and a reduced rate of paravalvular leak, according to new research published in JACC: Cardiovascular Interventions and EuroIntervention.
Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?
Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.

Endocarditis after TAVR: Increasingly rare, but incredibly fatal

The authors examined data from more than 134,000 TAVR patients, noting that 65% of endocarditis infections occurred within one year after the procedure.

September 8, 2020

TAVR outcomes similar after conscious sedation and general anesthesia

The new research out of Germany suggests both strategies are safe and effective for patients.

August 21, 2020

How population density can influence TAVR utilization, patient outcomes

Patient access to TAVR centers is often limited in rural areas where resources are in short supply.

August 20, 2020

How patient-specific simulations can improve TAVR care

Overall, the simulations inspired clinicians to change part of the treatment plan for 16 of 42 patients.

August 14, 2020

Outcomes ‘worse than expected’ when TAVR fails and surgery is required

The mortality rate was 17% for patients undergoing SAVR following a failed TAVR.

July 9, 2020

Outcomes continue to be favorable for low-risk TAVR patients receiving self-expanding valve

Low-risk transcatheter atortic valve replacement (TAVR) patients with aortic stenosis who receive the Evolut PRO continue to experience outcomes comparable to surgery.

June 24, 2020

Sapien 3 TAVR outcomes comparable to surgery after 5 years

Transcatheter aortic valve replacement (TAVR) with the Sapien 3 prosthesis achieved five-year clinical outcomes similar to surgical aortic valve replacement (SAVR).

June 24, 2020

Protamine administration during transcatheter aortic valve replacement (TAVR) is associated with a significant reduction in life-threatening and major bleeding complications.

June 23, 2020

TAVR

Hospital to pay $24.3M over TAVR allegations

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

Updated balloon-expandable TAVR valve from Edwards outperforming its predecessors

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?